Recommendations for using AR-targeted therapy as an approach when managing patients with metastatic castrate-sensitive prostate cancer.
EP. 1: Case Impressions: 66-Year-Old Man With mCSPC
Watch
EP. 2: Frontline Therapy for mCSPC
EP. 3: mCSPC: Patient Variables and Treatment Selection
EP. 4: The TITAN Trial in mCSPC
EP. 5: AR-Targeted Therapy for mCSPC: Adverse Events
EP. 6: AR-Targeted Therapy for mCSPC: Monitoring for Progression
EP. 7: mCSPC: Incorporating Newer Therapies Into Practice